Craft

Seegene

Stock Price

₩23.1 K

2024-10-29

Market Capitalization

₩1.1 T

2024-10-29

Revenue

₩367.4 B

FY, 2023

Seegene Summary

Company Summary

Overview
Seegene ((주)씨젠) is a company that manufactures molecular diagnostics products. It offers in vitro diagnostic (IVD) components, vial cap management systems, polymerase chain reaction (PCR) instruments, automated liquid handling workstations, etc. The company also provides MuDT, novel analytical PCR technology, which enables to detection of multiple targets with individuals; TOCE, a chemistry solution for the homogenous PCR; and DPO, amplification technology that enhances target.
Type
Public
Status
Active
Founded
2000
HQ
Seoul, KR | view all locations
Website
https://www.seegene.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Do Yeon Kim

    Do Yeon Kim, Chief People and Culture Officer

  • Jamie Yantzi

    Jamie Yantzi, President, Seegene Canada

Operating MetricsView all

Customer Sites

1.3K

Q2, 2020

Countries

48

Q2, 2020

Distributors

100

Q3, 2022

LocationsView all

8 locations detected

  • Seoul, Seoul HQ

    Korea (Republic of)

    209 Jamsil-ro

  • Walnut Creek, CA

    United States

    325 N Wiget Lane

  • Contagem, MG

    Brazil

    Av. Ápio Cardoso, 577

  • Toronto, ON

    Canada

    240 Richmond Street W

  • Düsseldorf, NRW

    Germany

    Merowingerpl. 1A

  • Genova, Liguria

    Italy

    Via Francesco Rolla, 26

and 2 others

Seegene Financials

Summary Financials

Revenue (Q2, 2024)
₩100.1B
Gross profit (Q2, 2024)
₩92.2B
Net income (Q2, 2024)
₩24.1B
Cash (Q2, 2024)
₩230.1B
EBIT (Q2, 2024)
₩20.5B
Enterprise value
$1.0T

Footer menu